what is ketamine used for in horses pdf

Overview of Ketamine in Horses

Ketamine is widely used in equine anesthesia for short‑term standing procedures like castration and as a core of total intravenous protocols. Its rapid onset, minimal cardiovascular impact, and analgesic synergy with other drugs make it a field and clinic staple. It aids analgesia during recovery quick

Historical Adoption and Current Usage

Ketamine entered equine practice in the late 1970s as a rapid‑acting dissociative anesthetic, quickly supplanting older agents that produced significant cardiovascular depression. Early field reports highlighted its ability to maintain stable blood pressure while providing profound analgesia, making it ideal for minor procedures performed in standing horses. By the early 1990s, veterinary conferences began to standardize dosing protocols, recommending an initial intravenous bolus of 1 cc per 100 kg (≈10 mg/kg) followed by a maintenance infusion of 0.5–1 mg/kg min⁻¹. These protocols were refined in 2004 when Matthews and colleagues published a seminal paper on constant‑rate infusions for analgesia, emphasizing the drug’s safety profile and ease of titration. Contemporary practice now routinely employs low‑dose ketamine (0.5–1 mg/kg) as a stand‑alone agent for short‑term standing anesthesia, such as castration or lameness work, and as a component of total intravenous anesthesia (TIVA) protocols in both field and clinic settings. The versatility of ketamine—its rapid onset, minimal respiratory depression, and synergistic analgesic effects when combined with benzodiazepines or opioids—has cemented its status as the most frequently used injectable anesthetic in horses today. Ongoing research continues to refine dosing strategies, investigate epidural applications for postoperative pain control, and explore its role in multimodal analgesia for large‑animal anesthesia. In addition, the 2010s saw the integration of ketamine into multimodal analgesic protocols for equine colic surgery, where it was paired with alpha‑2 agonists and opioids to reduce intraoperative nociception. Recent surveys indicate that over 70 % of large‑animal practitioners report using ketamine as part of their standard anesthetic repertoire, underscoring its entrenched role in equine medicine. The drug’s pharmacokinetic profile—rapid distribution, short half‑life, and minimal accumulation—allows for precise titration and quick recovery, which is particularly valuable in field situations where rapid turnaround is essential. Moreover, ketamine’s dissociative properties reduce the incidence of intraoperative excitement and agitation, thereby enhancing patient safety during short procedures. Finally, regulatory approvals in several countries have streamlined compounding and dispensing, making ketamine readily available to equine veterinarians worldwide.

Pharmacodynamics and Pharmacokinetics

Ketamine is an NMDA antagonist that induces anesthesia and analgesia. It distributes, reaching peak plasma levels within minutes. The drug’s half‑life is ~30–45 min, allowing recovery. Hepatic metabolism and renal excretion support a brief fast anesthetic period

Mechanism of Action on NMDA Receptors

Ketamine functions as a non‑competitive antagonist of the N‑methyl‑D‑aspartate (NMDA) receptor, a glutamate‑activated ion channel critical for excitatory neurotransmission. By binding to a distinct allosteric site within the receptor’s ion channel pore, ketamine blocks calcium and sodium influx, thereby dampening neuronal depolarization and synaptic plasticity. This blockade interrupts the excitatory cascade that underlies nociceptive transmission, producing profound analgesia. In the equine central nervous system, the drug’s action on NMDA receptors also reduces the central sensitization associated with pain, allowing for lower doses of additional analgesics. Moreover, ketamine’s NMDA antagonism contributes to its dissociative anesthetic state, characterized by a dissociation between sensory perception and motor output. The drug’s pharmacodynamic profile is dose‑dependent: low concentrations primarily yield analgesia, while higher levels produce full anesthesia. Importantly, ketamine’s modulation of NMDA activity preserves autonomic tone, which explains its minimal impact on cardiovascular function in horses. The rapid onset of action, typically within 30–60 seconds after intravenous administration, reflects efficient blood‑brain barrier penetration and high affinity for the NMDA receptor. The drug’s effects are reversible once the plasma concentration falls below the effective threshold, allowing for a predictable recovery period that is advantageous in field settings; Its rapid clearance allows for flexible dosing schedules during prolonged procedures swiftly.!!

Its use is also supported by evidence of reduced postoperative inflammation and faster return to baseline activity. Its pharmacological profile also supports multimodal analgesia when combined with opioids or alpha‑2 agonists, enhancing postoperative comfort while maintaining stable hemodynamics, making ketamine a versatile tool in equine anesthetic practice. It also reduces stress and improves recovery swiftly.!

Clinical Indications

Ketamine is used for short‑term standing procedures like castration and for total intravenous anesthesia (TIVA) in field and clinic. It offers rapid onset, analgesia, minimal cardiovascular impact, and quick recovery. Epidural use aids post‑op pain control. Quickly. and safe.

Short‑Term Standing Anesthesia for Minor Procedures

Ketamine, administered intravenously at 1–2 mg kg⁻¹, provides rapid, reliable anesthesia for standing procedures such as castration, hoof trimming, and minor orthopedic interventions. Its dissociative properties produce profound analgesia while maintaining spontaneous ventilation and cardiovascular stability, which is critical in field settings. The drug’s short half‑life (≈30 min) allows for quick recovery once the infusion stops, reducing the need for intensive post‑operative monitoring. In practice, a typical protocol involves an initial bolus of 1 mg kg⁻¹ h⁻¹ over 30–60 s, followed by a constant‑rate infusion of 0.5–1 mg kg⁻¹ h⁻¹. Redosing is usually 50 % of the initial bolus if the procedure extends beyond the expected duration. Adjuncts such as acepromazine (0.01–0.05 mg kg⁻¹) or butorphanol (0.1–0.2 mg kg⁻¹) are often combined to enhance sedation and analgesia, allowing for smoother induction and emergence. Monitoring of heart rate, respiratory rate, and capillary refill time remains essential, but the minimal respiratory depression associated with ketamine permits the use of simple monitoring equipment. Field veterinarians appreciate the drug’s portability, ease of use, and the ability to maintain standing anesthesia without the logistical challenges of transporting a horse to a hospital. Studies published in 2005 and 2004 have demonstrated that low‑dose ketamine protocols produce equivalent analgesia to conventional anesthetic agents while reducing recovery time and incidence of postoperative complications. Veterinary guidelines recommend careful titration and continuous monitoring to ensure patient safety and optimal outcomes, making ketamine a cornerstone of modern equine anesthesia. —OK! Thanks.!!

Total Intravenous Anesthesia (TIVA) Protocols

Ketamine is the backbone of equine total intravenous anesthesia (TIVA) protocols, especially for procedures requiring deep, long‑duration sedation such as castration, colic surgery, or limb reconstruction. A typical TIVA regimen begins with an induction bolus of 1 mg kg⁻¹ IV over 30–60 s, followed by a maintenance infusion of 0.5–1 mg kg⁻¹ h⁻¹. The infusion rate is adjusted based on clinical signs: a shallow response or inadequate analgesia warrants a 10–20 % increase, while signs of over‑sedation (hypotension, bradypnea) prompt a 10–20 % reduction. Redosing is usually 50 % of the initial bolus if the procedure exceeds the expected duration, and the infusion is tapered gradually to avoid sudden emergence. Ketamine’s dissociative action preserves spontaneous ventilation and maintains cardiovascular stability, allowing the horse to recover quickly once the infusion is stopped. Adjuncts such as acepromazine (0.01–0.05 mg kg⁻¹) or butorphanol (0.1–0.2 mg kg⁻¹) are often co‑administered to enhance sedation and analgesia, reducing the ketamine requirement and minimizing side effects. In field settings, the simplicity of a single IV line and the minimal need for advanced monitoring make ketamine‑based TIVA attractive. Recent studies (e.g., 2004 Matthews et al.) have validated the safety of low‑dose ketamine infusions, reporting stable hemodynamics and rapid recovery times. Protocols also recommend continuous monitoring of heart rate, respiratory rate, capillary refill, and temperature, and the use of a pulse oximeter when available. The combination of ketamine’s rapid onset, analgesic potency, and cardiovascular neutrality makes it the preferred agent for equine TIVA, providing a reliable, safe, and efficient anesthetic technique for both short and extended surgical procedures. Ketamine is typically prepared at 100 mg ml⁻¹, with 1 cc per 100 kg of body weight for the initial bolus. The infusion is usually delivered via a 20‑gauge catheter placed in the jugular vein, and the syringe is refreshed every 4–6 h to maintain potency. Recovery is usually smooth, with the horse regaining full consciousness within 5–10 min after infusion cessation.

Dosage and Administration

Induction: 1 mg kg⁻¹ IV over 30 s. Maintenance: 0.5–1 mg kg⁻¹ h⁻¹ infusion, titrated by clinical signs. Redose: 50 % of initial bolus if needed. Use 100 mg ml⁻¹ solution, 1 cc per 100 kg. Monitor vitals continuously. Ensure depth of anesthesia by adjusting infusion

Initial Intravenous Bolus Dosing

For standing or short‑term procedures, the standard induction dose of ketamine in the horse is 1 mg kg⁻¹ administered intravenously over 30 seconds to 1 minute. The solution is typically 100 mg ml⁻¹, so a 500‑kg animal receives 5 cc (500 mg) and a 1,000‑kg animal receives 10 cc (1,000 mg). The bolus should be given slowly to avoid a sudden spike in blood pressure and to allow the drug to distribute evenly into the central nervous system. Clinical signs of adequate depth include loss of the righting reflex, absence of head and neck muscle tone, and a flat, non‑reactive tongue. If the desired anesthetic plane is not achieved, a second bolus of 0.5 mg kg⁻¹ may be administered, but the total dose should not exceed 2 mg kg⁻¹ to prevent excessive cardiovascular depression. The bolus is often paired with a short‑acting hypnotic such as diazepam or acepromazine to enhance muscle relaxation and reduce the required ketamine dose. Monitoring of heart rate, respiratory rate, and arterial blood pressure is essential during the induction phase to detect any adverse effects early. The bolus dose is the foundation for a subsequent constant‑rate infusion, which maintains anesthesia while allowing for adjustments based on the procedure’s duration and the animal’s physiological response. This protocol ensures rapid recovery and minimal postoperative complications. Adjust as needed. care….

Constant Rate Infusion Parameters and Redosing

After the initial bolus, a continuous infusion of ketamine is started to maintain a steady anesthetic plane. The typical infusion rate is 0.5–1.0 mg kg⁻¹ h⁻¹, which translates to 5–10 mg kg⁻¹ day⁻¹ for a 500‑kg horse; Using a 100 mg ml⁻¹ solution, this equates to 0.05–0.10 ml kg⁻¹ min⁻¹ (2–4 ml min⁻¹ for a 500‑kg animal). The infusion should be started 5–10 minutes after the bolus and titrated to the desired depth of anesthesia, monitored by the absence of the righting reflex, muscle tone, and response to painful stimuli. If the horse shows signs of inadequate analgesia or sedation, the infusion rate can be increased by 0.2 mg kg⁻¹ h⁻¹ increments, but the total daily dose should not exceed 2 mg kg⁻¹. Redosing is usually performed by adding 0.5 mg kg⁻¹ of ketamine intravenously when the infusion has been running for 60–90 minutes and the anesthetic depth begins to wane. This approach allows for a smoother transition between the infusion and the recovery phase. Throughout the procedure, continuous monitoring of heart rate, respiratory rate, and blood pressure is essential to detect any hemodynamic changes. The infusion can be discontinued 10–15 minutes before the end of the surgery to facilitate rapid recovery, as ketamine’s elimination half‑life is approximately 2–3 hours in horses. Proper titration and vigilant monitoring reduce the risk of respiratory depression and cardiovascular instability, ensuring a safe and effective anesthetic course. All infusion parameters, including rate adjustments and redosing intervals, should be recorded in the surgical log to facilitate post‑operative evaluation and future protocol refinement. In practice, some clinicians combine ketamine with midazolam or propofol to achieve a balanced anesthetic, especially for longer procedures. The synergy between these agents allows for lower ketamine doses, thereby minimizing cardiovascular effects while maintaining adequate analgesia. Additionally, the use of a continuous infusion of ketamine can be complemented by intermittent boluses of local anesthetic at the surgical site to further reduce systemic ketamine requirements.

Safety and Contraindications

Ketamine is safe in most horses, but caution is needed in those with severe hypertension, cardiac disease, or respiratory compromise. Avoid use in pregnancy and when combined with drugs that depress respiration. Monitor vitals closely. Pre‑op check post‑opwatch.

Cardiovascular and Respiratory Considerations

Ketamine’s sympathomimetic action typically elevates heart rate and systolic blood pressure, providing a stable cardiovascular profile in most adult horses. However, in individuals with pre‑existing hypertension or cardiac arrhythmias, the pressor effect can precipitate tachyarrhythmias. Respiratory effects are generally mild; spontaneous ventilation is preserved, but the drug may cause transient bronchoconstriction or increased airway resistance, especially in asthmatic or reactive airway horses. Careful monitoring of pulse oximetry, capnography, and arterial blood gases is recommended during prolonged infusions. In patients with compromised pulmonary function, ketamine should be combined with opioids or benzodiazepines to reduce airway reflexes. Avoid high‑dose boluses in horses with severe aortic regurgitation or left‑ventricular dysfunction, as the sudden rise in afterload can worsen cardiac output. Additionally, ketamine can induce a brief period of apnea in some cases; supplemental oxygen and ventilation support should be readily available. Overall, ketamine is considered safe for cardiovascular and respiratory systems when dosed appropriately and monitored closely.

Clinicians should also be aware that ketamine can cause transient ocular hypertension and should monitor intraocular pressure in horses with pre‑existing eye disease. In addition, the drug’s dissociative properties may lead to post‑anesthetic disorientation, so a quiet recovery environment essential

Evidence Base and Key Publications

Key PDFs include Matthews et al. 2004 on ketamine constant‑rate infusion for analgesia, Bohanon 2005 on low‑dose standing anesthesia, and recent reviews summarizing equine ketamine pharmacology. These documents guide dosage, safety, and clinical protocols. 26

Significant PDFs and Studies on Ketamine Use in Horses

Matthews, N;S., et al. (2004). “How to Use a Ketamine Constant‑Rate Infusion in Horses for Analgesia.” This PDF outlines infusion rates, monitoring parameters, and safety guidelines for equine patients undergoing moderate‑to‑severe pain management.

Bohanon, T.C. (2005). “Low‑Dose Ketamine for Short‑Term Standing Anesthesia in the Horse.” Proceedings of the North American Veterinary Conference, 134. The study demonstrates a 0.5–1.0 mg/kg IV bolus followed by a 0.1 mg/kg/h infusion, achieving adequate sedation while preserving standing reflexes.

Smith, J., et al. (2012). “Comparative Efficacy of Ketamine‑Based TIVA Protocols in Large‑Animal Practice.” Journal of Equine Veterinary Science, 32(6), 345‑352. The authors compare ketamine‑propofol versus ketamine‑dexmedetomidine combinations, highlighting differences in recovery times and cardiovascular stability;

Lee, H., & Patel, R. (2018). “Ketamine Pharmacokinetics in Horses: A Review of Current Literature.” Equine Medicine Review, 9(2), 112‑127. The review consolidates data on absorption, distribution, metabolism, and excretion, providing a framework for dose adjustment in special populations.

Veterinary Health Center. “Anesthetic Drugs and Dosages Commonly Used in Horses.” This PDF compiles dosage tables for ketamine, propofol, and adjuncts, serving as a quick reference for field practitioners. Further reading in equine veterinary archives online

Practical Guidelines for Equine Practitioners

When integrating ketamine into routine equine practice, clinicians should adopt a structured workflow that balances efficacy, safety, and resource constraints. Begin with a thorough pre‑anesthetic assessment: confirm the horse’s cardiovascular stability, rule out pulmonary compromise, and verify that the patient is free of systemic disease that could alter drug metabolism. Document baseline heart rate, respiratory rate, capillary refill, and mucous membrane color. For standing procedures, a low‑dose bolus (0.5–1.0 mg/kg IV) followed by a maintenance infusion (0.05–0.1 mg/kg/h) typically yields adequate analgesia while preserving standing reflexes. Maintain a 20‑L/min oxygen flow during infusion to mitigate hypoxemia. Record infusion rates, total dose, and any adjuncts administered. Post‑procedure, observe for emergence time, muscle tone, and any signs of dysphoria. If the horse shows delayed recovery or respiratory depression, administer a reversal agent such as flumazenil or naloxone if opioids were used. Keep a log of each case to refine dosing protocols and improve patient safety over time.

In field settings, ensure a 5‑minute pre‑oxygenation period and maintain a 2‑L/min oxygen supplement during recovery. Use a 10‑mmHg cuff to monitor blood pressure continuously. If bradycardia occurs, consider a small dose of atropine (0.01 mg/kg IV). For horses with a history of colic, avoid ketamine alone; combine with a low‑dose opioid to blunt sympathetic surge. Ensure continuous heart rate monitoring and saturation!